Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026)
Kodiak Sciences (KOD) reported Change in Account Payables of -$733000.0 for Q1 2026, down 128.13% on a YoY basis from $2.6 million in Q1 2025, and down 145.08% quarter-over-quarter from $1.6 million in Q4 2025.
Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Change in Account Payables for 10 years, with the latest figure at -$733000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 128.13% year-over-year to -$733000.0; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 17.22% YoY), and the FY2025 full-year result was $8.1 million, up 183.26% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$733000.0, down from $1.6 million in the prior quarter.
- The five-year high for Change in Account Payables was $6.5 million in Q1 2022, with the low at -$11.1 million in Q1 2024.
- Historically, Change in Account Payables has averaged $288294.1 across 5 years, with a median of $637000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables soared 4042.42% — and 2024, when it slumped 485.42%.
- Kodiak Sciences' Change in Account Payables stood at -$5.4 million in 2022, then jumped by 145.74% to $2.5 million in 2023, then plunged by 74.35% to $637000.0 in 2024, then surged by 155.26% to $1.6 million in 2025, then sank by 145.08% to -$733000.0 in 2026.
- The last three Change in Account Payables figures came in at -$733000.0 (Q1 2026), $1.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -733,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -733,000.00 |
| Mar 31, 2026 | -733,000.00 |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 637,000.00 |
| Dec 31, 2024 | 637,000.00 |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | -791,000.00 |
| Jun 30, 2024 | -791,000.00 |
| Mar 31, 2024 | -11.12 Mn |
| Mar 31, 2024 | -11.12 Mn |
| Dec 31, 2023 | 2.48 Mn |
| Dec 31, 2023 | 2.48 Mn |